Quotes Alnylam Pharmaceuticals, Inc. Börse Stuttgart

Equities

DUL

US02043Q1076

Biotechnology & Medical Research

Market Closed - Börse Stuttgart 15:14:12 28/06/2024 BST 5-day change 1st Jan Change
227.6 EUR -1.47% Intraday chart for Alnylam Pharmaceuticals, Inc. +55.68% +29.61%

Quotes 5-day view

Delayed Quote Börse Stuttgart
Alnylam Pharmaceuticals, Inc.(DUL) : Historical Chart (5-day)
  25/06/2024 26/06/2024 27/06/2024 28/06/2024
Last 206.2 € 232.4 € 231 € 227.6 €
Volume 0 30 0 0
Change -1.95% +12.71% -0.60% -1.47%
Opening 207.40 226.00 226.20 229.30
High 207.40 232.40 231.00 229.40
Low 206.20 221.90 225.20 227.60

Performance

1 week+55.68%
Current month+64.99%
1 month+64.75%
3 months+58.50%
6 months+29.47%
Current year+29.61%
1 year+32.79%
3 years+56.48%
5 years+266.80%
10 years+388.05%

Volumes

markets
Capital turnover ratio
0.00
Float rotation
0.00

Basic data

Capitalization (EUR)
30 737 502 054
Capitalization (USD)
30 737 502 054
Net sales (USD)
1 828 292 000
Free-Float
99.58 %
Free-Float capitalization (EUR)
32 784 804 703
Free-Float capitalization (USD)
30 607 959 240
Average Daily Capital Traded
0%

Highs and lows

1 week
153.70
Extreme 153.7
232.40
1 month
134.00
Extreme 134
232.40
3 years
112.80
Extreme 112.8
232.40
5 years
62.48
Extreme 62.48
232.40
10 years
27.97
Extreme 27.966
232.40

Indicators

Moving average 5 days
221.50
Moving average 20 days
157.85
Moving average 50 days
145.31
Moving average 100 days
144.13
Price spread / (MMA5)
-2.68%
Price spread / (MMA20)
-30.64%
Price spread / (MMA50)
-36.15%
Price spread / (MMA100)
-36.68%
STIM
RSI 9 days
87.67
RSI 14 days
85.10

Historical data

DateOpeningHighLowEnd-of-dayVolume
Chart Alnylam Pharmaceuticals, Inc.
More charts

Monthly variations

Annual change

2024+29.61%
2023-20.29%
2022+47.36%
2021+41.22%
2020+1.83%
2019+75.64%
2018-44.96%
2017+199.84%
2016-57.88%
2015+7.65%
2014+68.25%
2013+254.20%
2012+110.98%
2011-14.15%
2010-41.13%
2009-24.45%
2008-15.62%
  1. Stock Market
  2. Equities
  3. ALNY Stock
  4. DUL Stock
  5. Quotes Alnylam Pharmaceuticals, Inc.